KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Work In Process (2016 - 2019)

Jazz Pharmaceuticals has reported Work In Process over the past 10 years, most recently at $31.3 million for Q1 2019.

  • Quarterly Work In Process changed N/A to $31.3 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $31.3 million through Mar 2019, changed N/A year-over-year, with the annual reading at $26.0 million for FY2018, 65.91% up from the prior year.
  • Work In Process was $31.3 million for Q1 2019 at Jazz Pharmaceuticals, up from $26.0 million in the prior quarter.
  • Over five years, Work In Process peaked at $31.3 million in Q1 2019 and troughed at $11.8 million in Q4 2015.
  • The 5-year median for Work In Process is $20.0 million (2017), against an average of $20.8 million.
  • Biggest five-year swings in Work In Process: decreased 16.04% in 2017 and later soared 65.91% in 2018.
  • Tracing JAZZ's Work In Process over 5 years: stood at $11.8 million in 2015, then skyrocketed by 57.9% to $18.7 million in 2016, then decreased by 16.04% to $15.7 million in 2017, then skyrocketed by 65.91% to $26.0 million in 2018, then grew by 20.05% to $31.3 million in 2019.
  • According to Business Quant data, Work In Process over the past three periods came in at $31.3 million, $26.0 million, and $24.0 million for Q1 2019, Q4 2018, and Q2 2018 respectively.